Morozov Andrey, Kalinin Nikita, Androsov Alexander, McFarland Jonathan, Scolarikos Andreas, Saidian Daniel, Gomez Rivas Juan, Somani Bhaskar, Enikeev Dmitry, Glybochko Petr, Gazimiev Magomed
Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
Institute for Clinical Medicine, Sechenov University, Moscow, Russia.
Int Urol Nephrol. 2023 Aug;55(8):1931-1936. doi: 10.1007/s11255-023-03584-3. Epub 2023 May 19.
To decrease complication rate, we developed a novel MG needle for kidney puncture consisting of a pointed cannula, an atraumatic mandrin-bulb and a spring mechanism pushing the mandrin-bulb forward.
To assess efficacy and safety of kidney puncture during percutaneous nephrolithotomy (PCNL) using a novel less-traumatic MG needle within a clinical trial.
We conducted a prospective randomized single-center study. In the experimental group, kidney puncture was performed with a novel MG needle while in the control group, standard Trocar or Chiba puncture needles were used.
hemoglobin drop.
A total of 67 patients were enrolled. Patients who underwent standard puncture (n = 33) had higher hemoglobin drop in the early postoperative period (p = 0.024). Although there was no statistical difference in overall complication rate between the two groups (p = 0.351), two severe Clavien-Dindo IIIa complications with urinoma occurred in patients from the control group.
Less-traumatic needle for kidney puncture may reduce hemoglobin drop and prevent the development of severe complications. At the same time, in terms of stone-free rate (SFR), the efficacy of PCNL remains the same regardless of the needle used for renal access.
为降低并发症发生率,我们研发了一种新型用于肾脏穿刺的MG针,它由一个尖套管、一个无创芯杆球囊和一个推动芯杆球囊向前的弹簧机构组成。
在一项临床试验中,评估使用新型微创MG针行经皮肾镜取石术(PCNL)时肾脏穿刺的有效性和安全性。
我们进行了一项前瞻性随机单中心研究。实验组使用新型MG针进行肾脏穿刺,而对照组使用标准套管针或千叶穿刺针。
血红蛋白下降。
共纳入67例患者。接受标准穿刺的患者(n = 33)术后早期血红蛋白下降幅度更大(p = 0.024)。尽管两组总体并发症发生率无统计学差异(p = 0.351),但对照组有2例患者发生了严重的Clavien-Dindo IIIa级尿瘤并发症。
微创肾脏穿刺针可能会减少血红蛋白下降并预防严重并发症的发生。同时,就无石率(SFR)而言,无论使用何种针进行肾脏穿刺通路建立,PCNL的疗效保持不变。